TGM2-mediated serotonylation of GPX4 confers ferroptosis resistance to promote gastric tumorigenesis
Protein monoaminylation represents a new layer of neural-cancer regulation, but its role in gastric tumorigenesis is not understood. Using untargeted plasma metabolomics, we revealed that the level of serotonin (5-HT) is significantly elevated in gastric cancer (GC) patients. Functionally, 5-HT treatment dramatically promoted GC cell proliferation and tumor growth in a dose-dependent manner. Importantly, this oncogenic effect was abrogated by the inhibition of transglutaminase 2 (TGM2), indicating a crucial role for protein serotonylation via a receptor-independent mechanism. Using a 5-HT-based chemoproteomic probe, we identified a broad spectrum of serotonylation targets, including key ferroptosis-related proteins such as glutathione peroxidase 4 (GPX4). Specifically, we found that GPX4 is serotonylated by TGM2 at residues Gln55 and Gln77, which increases GPX4 protein stability by attenuating its ubiquitin-mediated degradation, thereby conferring resistance to ferroptosis and facilitating tumor growth. Clinically, TGM2 levels were positively correlated with tumoral GPX4 expression in GC patient specimens. Collectively, our results establish TGM2-mediated GPX4 serotonylation as a key mechanism driving GC progression through ferroptosis resistance, highlighting its potential as both a diagnostic biomarker and a therapeutic target within the neural-tumor axis.
Authors
- Chunxiao Zhu
- Luyang Tian
- Zhaocai Zhou (ORCID: https://orcid.org/0000-0002-5441-3922)
- Run Zhang (ORCID: https://orcid.org/0000-0002-0943-824X)
- Sachiyo Nomura (ORCID: https://orcid.org/0000-0003-4293-6205)
- Kang Wei (ORCID: https://orcid.org/0000-0002-6211-6047)
- Xinwen Chen (ORCID: https://orcid.org/0000-0002-4052-8155)
- S T Zhang
- Yixuan Xie (ORCID: https://orcid.org/0000-0002-8512-6053)
- Xinru Zhang (ORCID: https://orcid.org/0000-0003-0643-390X)
- Fenghua Guo (ORCID: https://orcid.org/0000-0003-2885-4430)
- Dandan Geng (ORCID: https://orcid.org/0000-0002-3313-1571)
- X L Wang
- Meng Du
- Junping Bai
- Liwei An
- K F To
- Y J Tang
- H Li
- Chao Dong
- Zhangting Zhao
- Yi Han
- Shi Jiao (ORCID: https://orcid.org/0000-0003-3591-8973)
- Zhao Jin
- Wanting Li
- Weisheng Hu
Institutions
- Tongji University (CN)
- China Pharmaceutical University (CN)
- Chinese University of Hong Kong (HK)
- Anhui University of Science and Technology (CN)
- Fudan University (CN)
- Kunming Medical University (CN)
- Inner Mongolia University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Sichuan Provincial Architectural Design and Research Institute (China) (CN)
- Shanghai Industrial Boiler Research Institute (China) (CN)
- University of Tokyo Hospital (JP)
- Ministry of Education (KR)
- Prince of Wales Hospital (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Shanghai Tenth People's Hospital (CN)
- Huashan Hospital (CN)
- The University of Tokyo (JP)
Publication Details
- Journal
- Cell Discovery
- Published
- 2026-04-28
- DOI
- https://doi.org/10.1038/s41421-026-00885-6
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fudan University
- Science and Technology Commission of Shanghai Municipality
- Kunming Medical University